 | • レポートコード：D0GIR-02830 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、一般インフルエンザ診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。一般インフルエンザ診断の種類別市場規模（RIDT、ウイルス培養、DFA、血清学的アッセイ）、用途別市場規模（病院、臨床検査室、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：F. Hoffmann-La Roche、Abbott Laboratories、Quidel Corporation、bioMérieux、Thermo Fisher Scientific、DiaSorin、Becton, Dickinson, and Company ・地域別グローバル市場分析 2015年-2020年 ・一般インフルエンザ診断の北米市場（アメリカ、カナダ、メキシコ） ・一般インフルエンザ診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・一般インフルエンザ診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・一般インフルエンザ診断の南米市場（ブラジル、アルゼンチン） ・一般インフルエンザ診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：RIDT、ウイルス培養、DFA、血清学的アッセイ ・用途別分析：病院、臨床検査室、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The General Influenza Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global General Influenza Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
General Influenza Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, General Influenza Diagnostics market has been segmented into:
RIDT
Viral Culture
DFA
Serological Assays
By Application, General Influenza Diagnostics has been segmented into:
Hospitals
Clinical Laboratories
Other End-User
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global General Influenza Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level General Influenza Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global General Influenza Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the General Influenza Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and General Influenza Diagnostics Market Share Analysis
General Influenza Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, General Influenza Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the General Influenza Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in General Influenza Diagnostics are:
F. Hoffmann-La Roche
Abbott Laboratories
Quidel Corporation
bioMérieux
Thermo Fisher Scientific
DiaSorin
Becton, Dickinson, and Company
Among other players domestic and global, General Influenza Diagnostics market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 General Influenza Diagnostics Market Overview
1.1 Product Overview and Scope of General Influenza Diagnostics
1.2 Classification of General Influenza Diagnostics by Type
1.2.1 Global General Influenza Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global General Influenza Diagnostics Revenue Market Share by Type in 2019
1.2.3 RIDT
1.2.4 Viral Culture
1.2.5 DFA
1.2.6 Serological Assays
1.3 Global General Influenza Diagnostics Market by Application
1.3.1 Overview: Global General Influenza Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Other End-User
1.4 Global General Influenza Diagnostics Market by Regions
1.4.1 Global General Influenza Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of General Influenza Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) General Influenza Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) General Influenza Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) General Influenza Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) General Influenza Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) General Influenza Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business
2.1.3 F. Hoffmann-La Roche SWOT Analysis
2.1.4 F. Hoffmann-La Roche Product and Services
2.1.5 F. Hoffmann-La Roche General Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories SWOT Analysis
2.2.4 Abbott Laboratories Product and Services
2.2.5 Abbott Laboratories General Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Quidel Corporation
2.3.1 Quidel Corporation Details
2.3.2 Quidel Corporation Major Business
2.3.3 Quidel Corporation SWOT Analysis
2.3.4 Quidel Corporation Product and Services
2.3.5 Quidel Corporation General Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 bioMérieux
2.4.1 bioMérieux Details
2.4.2 bioMérieux Major Business
2.4.3 bioMérieux SWOT Analysis
2.4.4 bioMérieux Product and Services
2.4.5 bioMérieux General Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific SWOT Analysis
2.5.4 Thermo Fisher Scientific Product and Services
2.5.5 Thermo Fisher Scientific General Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 DiaSorin
2.6.1 DiaSorin Details
2.6.2 DiaSorin Major Business
2.6.3 DiaSorin Product and Services
2.6.4 DiaSorin General Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Becton, Dickinson, and Company
2.7.1 Becton, Dickinson, and Company Details
2.7.2 Becton, Dickinson, and Company Major Business
2.7.3 Becton, Dickinson, and Company Product and Services
2.7.4 Becton, Dickinson, and Company General Influenza Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global General Influenza Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 General Influenza Diagnostics Players Market Share
3.2.2 Top 10 General Influenza Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global General Influenza Diagnostics Revenue and Market Share by Regions
4.2 North America General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
5 North America General Influenza Diagnostics Revenue by Countries
5.1 North America General Influenza Diagnostics Revenue by Countries (2015-2020)
5.2 USA General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe General Influenza Diagnostics Revenue by Countries
6.1 Europe General Influenza Diagnostics Revenue by Countries (2015-2020)
6.2 Germany General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific General Influenza Diagnostics Revenue by Countries
7.1 Asia-Pacific General Influenza Diagnostics Revenue by Countries (2015-2020)
7.2 China General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
8 South America General Influenza Diagnostics Revenue by Countries
8.1 South America General Influenza Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue General Influenza Diagnostics by Countries
9.1 Middle East & Africa General Influenza Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global General Influenza Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global General Influenza Diagnostics Market Forecast by Type (2019-2024)
10.3 RIDT Revenue Growth Rate (2015-2025)
10.4 Viral Culture Revenue Growth Rate (2015-2025)
10.5 DFA Revenue Growth Rate (2015-2025)
10.6 Serological Assays Revenue Growth Rate (2015-2025)
11 Global General Influenza Diagnostics Market Segment by Application
11.1 Global General Influenza Diagnostics Revenue Market Share by Application (2015-2020)
11.2 General Influenza Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinical Laboratories Revenue Growth (2015-2020)
11.5 Other End-User Revenue Growth (2015-2020)
12 Global General Influenza Diagnostics Market Size Forecast (2021-2025)
12.1 Global General Influenza Diagnostics Market Size Forecast (2021-2025)
12.2 Global General Influenza Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America General Influenza Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe General Influenza Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific General Influenza Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America General Influenza Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa General Influenza Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global General Influenza Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of General Influenza Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global General Influenza Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market General Influenza Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global General Influenza Diagnostics Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 7. F. Hoffmann-La Roche General Influenza Diagnostics Major Business
Table 8. F. Hoffmann-La Roche General Influenza Diagnostics Total Revenue (USD Million) (2017-2018)
Table 9. F. Hoffmann-La Roche SWOT Analysis
Table 10. F. Hoffmann-La Roche General Influenza Diagnostics Product and Solutions
Table 11. F. Hoffmann-La Roche General Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Abbott Laboratories Corporate Information, Location and Competitors
Table 13. Abbott Laboratories General Influenza Diagnostics Major Business
Table 14. Abbott Laboratories General Influenza Diagnostics Total Revenue (USD Million) (2018-2019)
Table 15. Abbott Laboratories SWOT Analysis
Table 16. Abbott Laboratories General Influenza Diagnostics Product and Solutions
Table 17. Abbott Laboratories General Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Quidel Corporation Corporate Information, Location and Competitors
Table 19. Quidel Corporation General Influenza Diagnostics Major Business
Table 20. Quidel Corporation General Influenza Diagnostics Total Revenue (USD Million) (2017-2018)
Table 21. Quidel Corporation SWOT Analysis
Table 22. Quidel Corporation General Influenza Diagnostics Product and Solutions
Table 23. Quidel Corporation General Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. bioMérieux Corporate Information, Location and Competitors
Table 25. bioMérieux General Influenza Diagnostics Major Business
Table 26. bioMérieux General Influenza Diagnostics Total Revenue (USD Million) (2017-2018)
Table 27. bioMérieux SWOT Analysis
Table 28. bioMérieux General Influenza Diagnostics Product and Solutions
Table 29. bioMérieux General Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 31. Thermo Fisher Scientific General Influenza Diagnostics Major Business
Table 32. Thermo Fisher Scientific General Influenza Diagnostics Total Revenue (USD Million) (2017-2018)
Table 33. Thermo Fisher Scientific SWOT Analysis
Table 34. Thermo Fisher Scientific General Influenza Diagnostics Product and Solutions
Table 35. Thermo Fisher Scientific General Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. DiaSorin Corporate Information, Location and Competitors
Table 37. DiaSorin General Influenza Diagnostics Major Business
Table 38. DiaSorin General Influenza Diagnostics Total Revenue (USD Million) (2017-2018)
Table 39. DiaSorin SWOT Analysis
Table 40. DiaSorin General Influenza Diagnostics Product and Solutions
Table 41. DiaSorin General Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Becton, Dickinson, and Company Corporate Information, Location and Competitors
Table 43. Becton, Dickinson, and Company General Influenza Diagnostics Major Business
Table 44. Becton, Dickinson, and Company General Influenza Diagnostics Total Revenue (USD Million) (2017-2018)
Table 45. Becton, Dickinson, and Company SWOT Analysis
Table 46. Becton, Dickinson, and Company General Influenza Diagnostics Product and Solutions
Table 47. Becton, Dickinson, and Company General Influenza Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Global General Influenza Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 49. Global General Influenza Diagnostics Revenue Share by Players (2015-2020)
Table 50. Global General Influenza Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 51. Global General Influenza Diagnostics Revenue Market Share by Regions (2015-2020)
Table 52. North America General Influenza Diagnostics Revenue by Countries (2015-2020)
Table 53. North America General Influenza Diagnostics Revenue Market Share by Countries (2015-2020)
Table 54. Europe General Influenza Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 55. Asia-Pacific General Influenza Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 56. South America General Influenza Diagnostics Revenue by Countries (2015-2020)
Table 57. South America General Influenza Diagnostics Revenue Market Share by Countries (2015-2020)
Table 58. Middle East and Africa General Influenza Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 59. Middle East and Africa General Influenza Diagnostics Revenue Market Share by Countries (2015-2020)
Table 60. Global General Influenza Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 61. Global General Influenza Diagnostics Revenue Share by Type (2015-2020)
Table 62. Global General Influenza Diagnostics Revenue Forecast by Type (2021-2025)
Table 63. Global General Influenza Diagnostics Revenue by Application (2015-2020)
Table 64. Global General Influenza Diagnostics Revenue Share by Application (2015-2020)
Table 65. Global General Influenza Diagnostics Revenue Forecast by Application (2021-2025)
Table 66. Global General Influenza Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. General Influenza Diagnostics Picture
Figure 2. Global General Influenza Diagnostics Revenue Market Share by Type in 2019
Figure 3. RIDT Picture
Figure 4. Viral Culture Picture
Figure 5. DFA Picture
Figure 6. Serological Assays Picture
Figure 7. General Influenza Diagnostics Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinical Laboratories Picture
Figure 10. Other End-User Picture
Figure 11. Global General Influenza Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America General Influenza Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe General Influenza Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific General Influenza Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America General Influenza Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa General Influenza Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global General Influenza Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global General Influenza Diagnostics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players General Influenza Diagnostics Revenue Market Share in 2019
Figure 20. Global Top 10 Players General Influenza Diagnostics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global General Influenza Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global General Influenza Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 24. Global General Influenza Diagnostics Revenue Market Share by Regions in 2018
Figure 25. North America General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Europe General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. South America General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. North America General Influenza Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 31. North America General Influenza Diagnostics Revenue Market Share by Countries in 2019
Figure 32. USA General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Canada General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Europe General Influenza Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe General Influenza Diagnostics Revenue Market Share by Countries in 2019
Figure 37. Germany General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. UK General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. France General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Russia General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Italy General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific General Influenza Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific General Influenza Diagnostics Revenue Market Share by Countries in 2019
Figure 44. China General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Japan General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. Korea General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. India General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. South America General Influenza Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 50. South America General Influenza Diagnostics Revenue Market Share by Countries in 2019
Figure 51. Brazil General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa General Influenza Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa General Influenza Diagnostics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. UAE General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa General Influenza Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. Global General Influenza Diagnostics Revenue Share by Type (2015-2020)
Figure 60. Global General Influenza Diagnostics Revenue Share by Type in 2019
Figure 61. Global General Influenza Diagnostics Market Share Forecast by Type (2021-2025)
Figure 62. Global RIDT Revenue Growth Rate (2015-2020)
Figure 63. Global Viral Culture Revenue Growth Rate (2015-2020)
Figure 64. Global DFA Revenue Growth Rate (2015-2020)
Figure 65. Global Serological Assays Revenue Growth Rate (2015-2020)
Figure 66. Global General Influenza Diagnostics Revenue Share by Application (2015-2020)
Figure 67. Global General Influenza Diagnostics Revenue Share by Application in 2019
Figure 68. Global General Influenza Diagnostics Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Clinical Laboratories Revenue Growth Rate (2015-2020)
Figure 71. Global Other End-User Revenue Growth Rate (2015-2020)
Figure 72. Global General Influenza Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global General Influenza Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global General Influenza Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America General Influenza Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. Europe General Influenza Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific General Influenza Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. South America General Influenza Diagnostics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa General Influenza Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
インフルエンザ用迅速診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Rapid Diagnostic Testing for Influenza market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…- インフルエンザワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Vaccine for Influenza market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- インフルエンザNA阻害剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Influenza NA Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 分子インフルエンザ検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Molecular Influenza Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…
- インフルエンザ予防接種の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Influenza Vaccination market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4308.7 million by 2025, from USD 3603 million in 2019. The Influenza Vaccin…